Vir Biotechnology, Inc. Quarterly Return On Equity in % from Q3 2022 to Q3 2024

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Vir Biotechnology, Inc. quarterly/annual Return On Equity history and growth rate from Q3 2022 to Q3 2024.
  • Vir Biotechnology, Inc. Return On Equity for the quarter ending September 30, 2024 was -36.7 %, a 15.1% decline year-over-year.
  • Vir Biotechnology, Inc. annual Return On Equity for 2023 was -34.9 %, a 238% decline from 2022.
Return On Equity, Quarterly (%)
Return On Equity, YoY Quarterly Growth (%)
Period Value YoY Chg Change % Start Date End Date
Q3 2024 -36.7 -4.81 -15.1% Jul 1, 2024 Sep 30, 2024
Q2 2024 -30.9 -17.9 -136% Apr 1, 2024 Jun 30, 2024
Q1 2024 -32.6 -25.5 -362% Jan 1, 2024 Mar 31, 2024
Q4 2023 -34.9 -60.1 -238% Oct 1, 2023 Dec 31, 2023
Q3 2023 -31.9 -92.6 -153% Jul 1, 2023 Sep 30, 2023
Q2 2023 -13.1 Apr 1, 2023 Jun 30, 2023
Q1 2023 -7.05 Jan 1, 2023 Mar 31, 2023
Q4 2022 25.2 Oct 1, 2022 Dec 31, 2022
Q3 2022 60.7 Jul 1, 2022 Sep 30, 2022
* An asterisk sign (*) next to the value indicates that the value is likely invalid.